Language selection

Government of Canada / Gouvernement du Canada

Search

Updated guidance on the use of protein subunit COVID-19 vaccine (Novavax Nuvaxovid).: HP40-352/1-2024E-PDF ; HP40-352/2-2024E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.934797&sl=0

Publication information
Department/Agency
  • Public Health Agency of Canada, issuing body.
  • Canada. National Advisory Committee on Immunization, issuing body.
TitleUpdated guidance on the use of protein subunit COVID-19 vaccine (Novavax Nuvaxovid).
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Cover title.
  • Issued also in French under title: Mise à jour des directives sur l'utilisation du vaccin à sous-unités protéiques contre la COVID-19 (Nuvaxovid de Novavax).
  • At head of title: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
  • Pub.: 230829 (report). Pub.: 230831 (summary).
  • Includes bibliographical references.
Publishing information
  • Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, March 8, 2024.
  • ©2024
Description1 online resource (12 pages, 3 unnumbered pages) + 1 summary (4 pages)
ISBN9780660705675 9780660705682
Catalogue number
  • HP40-352/1-2024E-PDF
  • HP40-352/2-2024E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: